Log In
Print this Print this

Visanne (MJR-35) (formerly Endometrion)

  Manage Alerts
Collapse Summary General Information
Company Bayer AG
DescriptionOral formulation of progestin dienogest
Molecular Target GnRH/LHRH receptor
Mechanism of ActionGnRH/LHRH receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationEndometriosis
Indication DetailsTreat endometriosis; Treat uterine adenomyosis
Regulatory Designation
PartnerMochida Pharmaceutical Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today